18 patents currently held
9 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Nov 2029. from the record
Of the 9 now held by other companies, 9 name Dsrco B.V. as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
Nov 2029
Next term end
10
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Feb 2038 · High confidence
Also notable
Ends Feb 2033 · High confidence
Also notable
Ends Feb 2032 · High confidence
Systems and Methods for Managing and Analyzing Data Generated by an Implantable Device
US 10,769,244
Cited by 47 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2038.
Apparatus and Methods for Treating Intracorporeal Fluid Accumulation
US 10,252,037
Cited by 41 later US patents, top 10% of utility patents granted in 2019 in our data. Protection runs to 2033.
Systems and Methods for Treating Chronic Liver Failure Based on Peritoneal Dialysis
US 8,585,635
The most cited patent in this portfolio, cited by 73 later US patents, top 10% of utility patents granted in 2013 in our data. Protection runs to 2032.
Formerly held, still cited
Notable
Ends May 2030 · High confidence
The most cited patent in this portfolio, cited by 129 later US patents, top 5% of utility patents granted in 2012 in our data. Protection runs to 2030.
now held by Dsrco B.V.
Also notable
Ends May 2038 · High confidence
Cited by 16 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2038. A terminal disclaimer caps this term to an earlier patent's.
now held by Dsrco B.V.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 26, 2026The maintenance fee for Apparatus and Methods for Treating Intracorporeal Fluid Accumulation (US 9,039,652) comes due Nov 26, 2026. Unpaid by May 26, 2027, it lapses early.
- 1 fee due Mar 29, 2027The maintenance fee for Implantable Catheters with Staggered Slits, and Methods of Using Same (US 9,144,660) comes due Mar 29, 2027. Unpaid by Sep 29, 2027, it lapses early.
- 2 fees due Apr 6 to 24, 2027 · next Apr 6
- 2 fees due Jun 3 to 26, 2027 · next Jun 3
- 1 fee due Aug 25, 2027The maintenance fee for Systems and Methods for Fluid Management (US 10,569,003) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 10 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D743,542 | Catheter with Staggered Slits In force · High confidence | In force | High confidence | |
| US D743,543 | Catheter with Staggered Slits In force · High confidence | In force | High confidence | |
| US 10,569,003 | Systems and Methods for Fluid Management In force · High confidence | In force | High confidence | |
| US 8,585,635 | Systems and Methods for Treating Chronic Liver Failure Based on Peritoneal Dialysis In force · High confidence | In force | High confidence | |
| US 10,252,037 | Apparatus and Methods for Treating Intracorporeal Fluid Accumulation In force · High confidence | In force | High confidence | |
| US 11,235,131 | Apparatus and Methods for Treating Intracorporeal Fluid Accumulation In force · High confidence | In force | High confidence | |
| US 9,039,652 | Apparatus and Methods for Treating Intracorporeal Fluid Accumulation In force · High confidence | In force | High confidence | |
| US 9,149,613 | Apparatus and Methods for Treating Intracorporeal Fluid Accumulation In force · High confidence | In force | High confidence | |
| US 9,675,327 | Apparatus and Methods for Noninvasive Monitoring of Cancerous Cells In force · High confidence | In force | High confidence | |
| US 9,144,660 | Implantable Catheters with Staggered Slits, and Methods of Using Same In force · High confidence | In force | High confidence |
Also on record, not counted in the 18: 9 patents in force now held by others · 14 patents ended · 4 applications pending. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.